PLK1 contributes to autophagy by regulating MYC stabilization in osteosarcoma cells

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Polo-like kinase 1 (PLK1) drives cancer cell growth and proliferation, often serving as a tumor marker.
• MYC overexpression is a hallmark of many cancers, regulating essential cellular processes.
• The mutual crosstalk between PLK1 and MYC in tumor progression remains understudied.

Purpose of the Study:

• To elucidate the mechanistic interplay between PLK1 and MYC in osteosarcoma progression.
• To investigate how PLK1 and MYC regulate osteosarcoma cell growth and proliferation.

Main Methods:

• Western blot analysis to assess protein levels.
• In vivo experiments utilizing female FOX CHASE severe combined immunodeficient mice models.
• Pharmacological inhibition of PLK1 using BI2536 in a xenograft tumor model.

Main Results:

• PLK1 and MYC promote osteosarcoma cell proliferation through the autophagy pathway.
• PLK1 directly contributes to MYC protein stabilization; PLK1 inhibition leads to MYC degradation.
• PLK1 inhibition resulted in deregulated MYC target genes and significantly delayed tumor growth in vivo.

Conclusions:

• PLK1 is essential for MYC stabilization and promotes osteosarcoma cell proliferation via autophagy.
• PLK1 inhibition effectively reduces MYC protein levels and hinders tumor growth.
• PLK1 represents a promising therapeutic target for MYC-amplified osteosarcoma.